131 related articles for article (PubMed ID: 18092266)
1. Increased titres of anti-nuclear antibodies do not predict the development of associated disease in the absence of initial suggestive signs and symptoms.
Dinser R; Braun A; Jendro MC; Engel A
Scand J Rheumatol; 2007; 36(6):448-51. PubMed ID: 18092266
[TBL] [Abstract][Full Text] [Related]
2. Outcome of positive antinuclear antibodies in individuals without connective tissue disease.
Myckatyn SO; Russell AS
J Rheumatol; 2003 Apr; 30(4):736-9. PubMed ID: 12672192
[TBL] [Abstract][Full Text] [Related]
3. Antinuclear antibodies in patients with polymorphic light eruption: a long-term follow-up study.
Tzaneva S; Volc-Platzer B; Kittler H; Hönigsmann H; Tanew A
Br J Dermatol; 2008 May; 158(5):1050-4. PubMed ID: 18341657
[TBL] [Abstract][Full Text] [Related]
4. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.
Vos PA; Bast EJ; Derksen RH
Rheumatology (Oxford); 2006 May; 45(5):629-35. PubMed ID: 16368728
[TBL] [Abstract][Full Text] [Related]
5. The initial manifestations and final diagnosis of patients with high and low titers of antinuclear antibodies after 6 months of follow-up.
Wang KY; Yang YH; Chuang YH; Chan PJ; Yu HH; Lee JH; Wang LC; Chiang BL
J Microbiol Immunol Infect; 2011 Jun; 44(3):222-8. PubMed ID: 21524618
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and patterns of anti-nuclear antibodies in Korean children with juvenile idiopathic arthritis according to ILAR criteria.
Shin JI; Kim KH; Chun JK; Lee TJ; Kim KJ; Kim HS; Kim DS
Scand J Rheumatol; 2008; 37(5):348-51. PubMed ID: 18666025
[TBL] [Abstract][Full Text] [Related]
7. The outcome of children referred to a pediatric rheumatology clinic with a positive antinuclear antibody test but without an autoimmune disease.
Deane PM; Liard G; Siegel DM; Baum J
Pediatrics; 1995 Jun; 95(6):892-5. PubMed ID: 7761217
[TBL] [Abstract][Full Text] [Related]
8. From ANA to ENA: how to proceed?
Damoiseaux JG; Tervaert JW
Autoimmun Rev; 2006 Jan; 5(1):10-7. PubMed ID: 16338206
[TBL] [Abstract][Full Text] [Related]
9. Increased percentages of autoantibodies in immunoglobulin A-deficient children do not correlate with clinical manifestations.
Gulez N; Karaca NE; Aksu G; Kutukculer N
Autoimmunity; 2009 Jan; 42(1):74-9. PubMed ID: 19127458
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological evaluation of in vivo epidermal nuclear fluorescence.
Sousa JX; Miyamoto D; Zimbres JM; Costa DV; Aoki V
Clin Exp Dermatol; 2009 Apr; 34(3):314-8. PubMed ID: 19040522
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis.
Granito A; Muratori P; Muratori L; Pappas G; Cassani F; Worthington J; Ferri S; Quarneti C; Cipriano V; de Molo C; Lenzi M; Chapman RW; Bianchi FB
Aliment Pharmacol Ther; 2007 Sep; 26(6):831-8. PubMed ID: 17767467
[TBL] [Abstract][Full Text] [Related]
12. The prevalence and significance of positive antinuclear antibodies in patients with fibromyalgia syndrome: 2-4 years' follow-up.
Al-Allaf AW; Ottewell L; Pullar T
Clin Rheumatol; 2002 Nov; 21(6):472-7. PubMed ID: 12447630
[TBL] [Abstract][Full Text] [Related]
13. Concentration of antibodies to extractable nuclear antigens and disease activity in systemic lupus erythematosus.
Agarwal S; Harper J; Kiely PD
Lupus; 2009 Apr; 18(5):407-12. PubMed ID: 19318392
[TBL] [Abstract][Full Text] [Related]
14. Favorable outcomes of autoimmune hepatitis in a community clinic setting.
Seo S; Toutounjian R; Conrad A; Blatt L; Tong MJ
J Gastroenterol Hepatol; 2008 Sep; 23(9):1410-4. PubMed ID: 18373564
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
[TBL] [Abstract][Full Text] [Related]
16. Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians.
Suarez-Almazor ME; Gonzalez-Lopez L; Gamez-Nava JI; Belseck E; Kendall CJ; Davis P
J Rheumatol; 1998 Oct; 25(10):1980-5. PubMed ID: 9779854
[TBL] [Abstract][Full Text] [Related]
17. A positive antinuclear antibody test predicts for a poor response to initial steroid therapy in adults with idiopathic thrombocytopenic purpura.
Abbasi SY; Milhem M; Zaru L
Ann Hematol; 2008 Jun; 87(6):459-62. PubMed ID: 18265983
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the LIAISON ANA screen assay for antinuclear antibody testing in autoimmune diseases.
Ghillani P; Rouquette AM; Desgruelles C; Hauguel N; Le Pendeven C; Piette JC; Musset L
Ann N Y Acad Sci; 2007 Aug; 1109():407-13. PubMed ID: 17785329
[TBL] [Abstract][Full Text] [Related]
19. Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum.
Nifli AP; Notas G; Mamoulaki M; Niniraki M; Ampartzaki V; Theodoropoulos PA; Kopnitsky MJ; Castanas E
J Immunol Methods; 2006 Apr; 311(1-2):189-97. PubMed ID: 16554066
[TBL] [Abstract][Full Text] [Related]
20. [Hashimoto's thyroiditis and autoimmunity parameters: descriptive study].
Fiducia M; Lauretta R; Lunghi R; Kyanvash S; Pallotti S
Minerva Med; 2007 Apr; 98(2):95-9. PubMed ID: 17519851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
